Included support
- +Hospital matching
- +Record review
- +Care coordination
- +Travel support
- +Interpretation support

Retroperitoneal Lymph Node Dissection (RPLND) may be considered in non-seminomatous germ cell tumors (NSGCT) with residual or stable retroperitoneal lymph nodes after systemic therapy, or as an early selective staging/treatment option. The decision depends on lesion size and location, changes in tum
24-72h
Response window
Approx. $8,000
Treatment fee
Peking Union Medical College Hospital - Beijing - Grade 3A
Ruijin Hospital - Shanghai - Grade 3A
West China Hospital - Chengdu - Grade 3A
Let us coordinate the treatment journey with you.
This procedure targets suspected affected lymph nodes in the retroperitoneum, with open or laparoscopic approaches available. Typically performed under general anesthesia, the retroperitoneum is accessed, and important blood vessels and ureters are identified and protected. Lymphatic tissue is resected according to a predetermined template, with nerve sparing performed as necessary (if applicable). The specimen is sent for pathology. Postoperative monitoring focuses on urine output, bowel movements, and drainage. The goal is to remove residual lesions and obtain staging information. The above is general health information and not medical advice; specific details are subject to specialist evaluation and hospital protocols.
This procedure targets suspected affected lymph nodes in the retroperitoneum, with open or laparoscopic approaches available. Typically performed under general anesthesia, the retroperitoneum is accessed, and important blood vessels and ureters are identified and protected. Lymphatic tissue is resected according to a predetermined template, with nerve sparing performed as necessary (if applicable). The specimen is sent for pathology. Postoperative monitoring focuses on urine output, bowel movements, and drainage. The goal is to remove residual lesions and obtain staging information. The above is general health information and not medical advice; specific details are subject to specialist evaluation and hospital protocols.

Combining preoperative consultation and postoperative follow-up, an overall stay in China of 3–5 weeks is generally recommended. The exact number of days depends on individual assessment and scheduling.

Tell us about your Testicular Cancer case and we will help match you with the right hospital, specialist, and travel pathway.